• J. Toxicol. Clin. Toxicol. · Jan 2001

    Review

    Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices.

    • J. Toxicol. Clin. Toxicol. 2001 Jan 1; 39 (1): 85-100.

    AbstractThese recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…